Phase 3 Readout~month

Phase 3 Topline: An Open-label Phase 1/2/3 Study Consisting of a Phase 1/2 Safety and Dose-escalation and Phase 3 Dos

Drug
rett
Indication
Rett Syndrome

Other upcoming events for TSHA

Phase 3 ReadoutPhase 3 Topline: ASPIRE Study: A Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Open-label Phase 1/2/3 Study Consisting of a Phase 1/2 Safety and Dose-escalation and Phase 3 Dos — TSHA Phase 3 Readout | BioSniper